Global Tissue Diagnostics Instrument Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 158385
- Pages: 150
-
Format:
Summary
The global Tissue Diagnostics Instrument market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Slide-staining Systems
Scanners
Tissue-processing Systems
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Roche (Switzerland)
Danaher (US)
Thermo Fisher Scientific (US)
Abbott (US)
Agilent Technologies (US)
Merck (Germany)
Sakura Finetek Japan (Japan)
Abcam (UK)
BD (US)
QIAGEN (Netherlands)
Sienna Cancer Diagnostics (Australia)
Royal Philips (Netherlands)
A. Menarini Diagnostics (Italy)
Cell Signaling Technology (US)
Enzo Life Sciences (US)
Master Diagnstica (Spain)
TissueGnostics (Austria)
Bio SB (US)
MedImmune (US)
Cernostics (US)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Breast cancer
Gastric cancer
Lymphoma
Prostate cancer
Non-small cell lung cancer
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Tissue Diagnostics Instrument of Research
1.1.1 Definition
1.1.2 Specifications of Tissue Diagnostics Instrument
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Slide-staining Systems Overview
1.2.1.2 Scanners Overview
1.2.1.3 Tissue-processing Systems Overview
1.2.1.4 Others Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Breast cancer
1.3.1.2 Gastric cancer
1.3.1.3 Lymphoma
1.3.1.4 Prostate cancer
1.3.1.5 Non-small cell lung cancer
1.3.1.6 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Slide-staining Systems Market Size 2018-2023
3.1.1.1 Global Slide-staining Systems Market Size and Growth Rate 2018-2023
3.1.1.2 Global Slide-staining Systems Market Size by Region 2018-2023
3.1.2 Scanners Market Size 2018-2023
3.1.2.1 Global Scanners Market Size and Growth Rate 2018-2023
3.1.2.2 Global Scanners Market Size by Region 2018-2023
3.1.3 Tissue-processing Systems Market Size 2018-2023
3.1.3.1 Global Tissue-processing Systems Market Size and Growth Rate 2018-2023
3.1.3.2 Global Tissue-processing Systems Market Size by Region 2018-2023
3.1.4 Others Market Size 2018-2023
3.1.4.1 Global Others Market Size and Growth Rate 2018-2023
3.1.4.2 Global Others Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Slide-staining Systems Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Slide-staining Systems Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Slide-staining Systems Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Scanners Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Scanners Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Scanners Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 Tissue-processing Systems Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global Tissue-processing Systems Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global Tissue-processing Systems Market Estimates and Forecasts by Region 2024E-2030F
3.2.4 Others Market Estimates and Forecasts 2024E-2030F
3.2.4.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
3.2.4.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Breast cancer Market Size 2018-2023
4.1.1.1 Global Breast cancer Market Size and Growth Rate 2018-2023
4.1.1.2 Global Breast cancer Market Size by Region 2018-2023
4.1.2 Gastric cancer Market Size 2018-2023
4.1.2.1 Global Gastric cancer Market Size and Growth Rate 2018-2023
4.1.2.2 Global Gastric cancer Market Size by Region 2018-2023
4.1.3 Lymphoma Market Size 2018-2023
4.1.3.1 Global Lymphoma Market Size and Growth Rate 2018-2023
4.1.3.2 Global Lymphoma Market Size by Region 2018-2023
4.1.4 Prostate cancer Market Size 2018-2023
4.1.4.1 Global Prostate cancer Market Size and Growth Rate 2018-2023
4.1.4.2 Global Prostate cancer Market Size by Region 2018-2023
4.1.5 Non-small cell lung cancer Market Size 2018-2023
4.1.5.1 Global Non-small cell lung cancer Market Size and Growth Rate 2018-2023
4.1.5.2 Global Non-small cell lung cancer Market Size by Region 2018-2023
4.1.6 Others Market Size 2018-2023
4.1.6.1 Global Others Market Size and Growth Rate 2018-2023
4.1.6.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Breast cancer Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Breast cancer Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Breast cancer Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Gastric cancer Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Gastric cancer Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Gastric cancer Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Lymphoma Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Lymphoma Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Lymphoma Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Prostate cancer Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Prostate cancer Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Prostate cancer Market Estimates and Forecasts by Region 2024E-2030F
4.2.5 Non-small cell lung cancer Market Estimates and Forecasts 2024E-2030F
4.2.5.1 Global Non-small cell lung cancer Market Forecasts and Growth Rate 2024E-2030F
4.2.5.2 Global Non-small cell lung cancer Market Estimates and Forecasts by Region 2024E-2030F
4.2.6 Others Market Estimates and Forecasts 2024E-2030F
4.2.6.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.6.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Tissue Diagnostics Instrument Market Competition
7.1.1 Global Tissue Diagnostics Instrument Market by Companies
7.1.2 Global Tissue Diagnostics Instrument Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Roche (Switzerland)
8.1.1 Roche (Switzerland) Company Profile
8.1.2 Roche (Switzerland) Product Portfolio
8.1.3 Roche (Switzerland) Business Performance
8.1.4 Roche (Switzerland) Development Overview
8.2 Danaher (US)
8.2.1 Danaher (US) Company Profile
8.2.2 Danaher (US) Product Portfolio
8.2.3 Danaher (US) Business Performance
8.2.4 Danaher (US) Development Overview
8.3 Thermo Fisher Scientific (US)
8.3.1 Thermo Fisher Scientific (US) Company Profile
8.3.2 Thermo Fisher Scientific (US) Product Portfolio
8.3.3 Thermo Fisher Scientific (US) Business Performance
8.3.4 Thermo Fisher Scientific (US) Development Overview
8.4 Abbott (US)
8.4.1 Abbott (US) Company Profile
8.4.2 Abbott (US) Product Portfolio
8.4.3 Abbott (US) Business Performance
8.4.4 Abbott (US) Development Overview
8.5 Agilent Technologies (US)
8.5.1 Agilent Technologies (US) Company Profile
8.5.2 Agilent Technologies (US) Product Portfolio
8.5.3 Agilent Technologies (US) Business Performance
8.5.4 Agilent Technologies (US) Development Overview
8.6 Merck (Germany)
8.6.1 Merck (Germany) Company Profile
8.6.2 Merck (Germany) Product Portfolio
8.6.3 Merck (Germany) Business Performance
8.6.4 Merck (Germany) Development Overview
8.7 Sakura Finetek Japan (Japan)
8.7.1 Sakura Finetek Japan (Japan) Company Profile
8.7.2 Sakura Finetek Japan (Japan) Product Portfolio
8.7.3 Sakura Finetek Japan (Japan) Business Performance
8.7.4 Sakura Finetek Japan (Japan) Development Overview
8.8 Abcam (UK)
8.8.1 Abcam (UK) Company Profile
8.8.2 Abcam (UK) Product Portfolio
8.8.3 Abcam (UK) Business Performance
8.8.4 Abcam (UK) Development Overview
8.9 BD (US)
8.9.1 BD (US) Company Profile
8.9.2 BD (US) Product Portfolio
8.9.3 BD (US) Business Performance
8.9.4 BD (US) Development Overview
8.10 QIAGEN (Netherlands)
8.10.1 QIAGEN (Netherlands) Company Profile
8.10.2 QIAGEN (Netherlands) Product Portfolio
8.10.3 QIAGEN (Netherlands) Business Performance
8.10.4 QIAGEN (Netherlands) Development Overview
8.11 Sienna Cancer Diagnostics (Australia)
8.11.1 Sienna Cancer Diagnostics (Australia) Company Profile
8.11.2 Sienna Cancer Diagnostics (Australia) Product Portfolio
8.11.3 Sienna Cancer Diagnostics (Australia) Business Performance
8.11.4 Sienna Cancer Diagnostics (Australia) Development Overview
8.12 Royal Philips (Netherlands)
8.12.1 Royal Philips (Netherlands) Company Profile
8.12.2 Royal Philips (Netherlands) Product Portfolio
8.12.3 Royal Philips (Netherlands) Business Performance
8.12.4 Royal Philips (Netherlands) Development Overview
8.13 A. Menarini Diagnostics (Italy)
8.13.1 A. Menarini Diagnostics (Italy) Company Profile
8.13.2 A. Menarini Diagnostics (Italy) Product Portfolio
8.13.3 A. Menarini Diagnostics (Italy) Business Performance
8.13.4 A. Menarini Diagnostics (Italy) Development Overview
8.14 Cell Signaling Technology (US)
8.14.1 Cell Signaling Technology (US) Company Profile
8.14.2 Cell Signaling Technology (US) Product Portfolio
8.14.3 Cell Signaling Technology (US) Business Performance
8.14.4 Cell Signaling Technology (US) Development Overview
8.15 Enzo Life Sciences (US)
8.15.1 Enzo Life Sciences (US) Company Profile
8.15.2 Enzo Life Sciences (US) Product Portfolio
8.15.3 Enzo Life Sciences (US) Business Performance
8.15.4 Enzo Life Sciences (US) Development Overview
8.16 Master Diagnstica (Spain)
8.16.1 Master Diagnstica (Spain) Company Profile
8.16.2 Master Diagnstica (Spain) Product Portfolio
8.16.3 Master Diagnstica (Spain) Business Performance
8.16.4 Master Diagnstica (Spain) Development Overview
8.17 TissueGnostics (Austria)
8.17.1 TissueGnostics (Austria) Company Profile
8.17.2 TissueGnostics (Austria) Product Portfolio
8.17.3 TissueGnostics (Austria) Business Performance
8.17.4 TissueGnostics (Austria) Development Overview
8.18 Bio SB (US)
8.18.1 Bio SB (US) Company Profile
8.18.2 Bio SB (US) Product Portfolio
8.18.3 Bio SB (US) Business Performance
8.18.4 Bio SB (US) Development Overview
8.19 MedImmune (US)
8.19.1 MedImmune (US) Company Profile
8.19.2 MedImmune (US) Product Portfolio
8.19.3 MedImmune (US) Business Performance
8.19.4 MedImmune (US) Development Overview
8.20 Cernostics (US)
8.20.1 Cernostics (US) Company Profile
8.20.2 Cernostics (US) Product Portfolio
8.20.3 Cernostics (US) Business Performance
8.20.4 Cernostics (US) Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
